Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gold

Showing results (621-630 of 721) with videos related to

Pageof 73
Sort By:
The Journal of Urology|June 26, 2018
Comparison of Elastic and Rigid Registration during Magnetic Resonance Imaging/Ultrasound Fusion-Guided Prostate Biopsy: A Multi-Operator Phantom StudyGraham R Hale, Marcin Czarniecki, Alexis Cheng, et al.
The Oncologist|August 30, 2014
A phase I/II study combining erlotinib and dasatinib for non-small cell lung cancerKathryn A Gold, J Jack Lee, Nusrat Harun, et al.
International Journal of Cancer|March 16, 2012
Molecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16Jacolien van der Marel, Wim G V Quint, Mark Schiffman, et al.
Urology|May 14, 2023
Optimal Prostate Cancer Diagnostic Pathways for Men With Prostatomegaly in the MRI EraSamuel A Gold, Ramy Goueli, Thomaz Rodrigues Mostardeiro, et al.
The Journal of Urology|January 26, 2019
When to Biopsy the Seminal Vesicles: A Validated Multiparametric Magnetic Resonance Imaging and Target Driven Model to Detect Seminal Vesicle Invasion of Prostate CancerSamuel A Gold, Joanna H Shih, Soroush Rais-Bahrami, et al.
Journal of Lower Genital Tract Disease|April 4, 2020
Challenges Associated With Cervical Cancer Screening and Management in Obese Women: A Provider PerspectiveMegan A Clarke, L Stewart Massad, Michelle J Khan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2009
Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancerSharmila Makhija, Lukas C Amler, Dana Glenn, et al.
Gynecologic Oncology|November 13, 2007
Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovaryKathleen N Moore, Katherine M Moxley, Amanda Nickles Fader, et al.
Stem Cells (Dayton, Ohio)|April 23, 2013
Multipotent stromal cells alleviate inflammation, neuropathology, and symptoms associated with globoid cell leukodystrophy in the twitcher mouseBrittni A Scruggs, Xiujuan Zhang, Annie C Bowles, et al.
Gynecologic Oncology|January 17, 2013
A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: a Gynecologic Oncology Group studyR J Schilder, M W Sill, H A Lankes, et al.
Pageof 73

Showing results (621-630 of 721) with videos related to

Sort By:
Pageof 73
The Journal of Urology|June 26, 2018
Comparison of Elastic and Rigid Registration during Magnetic Resonance Imaging/Ultrasound Fusion-Guided Prostate Biopsy: A Multi-Operator Phantom StudyGraham R Hale, Marcin Czarniecki, Alexis Cheng, et al.
The Oncologist|August 30, 2014
A phase I/II study combining erlotinib and dasatinib for non-small cell lung cancerKathryn A Gold, J Jack Lee, Nusrat Harun, et al.
International Journal of Cancer|March 16, 2012
Molecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16Jacolien van der Marel, Wim G V Quint, Mark Schiffman, et al.
Urology|May 14, 2023
Optimal Prostate Cancer Diagnostic Pathways for Men With Prostatomegaly in the MRI EraSamuel A Gold, Ramy Goueli, Thomaz Rodrigues Mostardeiro, et al.
The Journal of Urology|January 26, 2019
When to Biopsy the Seminal Vesicles: A Validated Multiparametric Magnetic Resonance Imaging and Target Driven Model to Detect Seminal Vesicle Invasion of Prostate CancerSamuel A Gold, Joanna H Shih, Soroush Rais-Bahrami, et al.
Journal of Lower Genital Tract Disease|April 4, 2020
Challenges Associated With Cervical Cancer Screening and Management in Obese Women: A Provider PerspectiveMegan A Clarke, L Stewart Massad, Michelle J Khan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2009
Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancerSharmila Makhija, Lukas C Amler, Dana Glenn, et al.
Gynecologic Oncology|November 13, 2007
Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovaryKathleen N Moore, Katherine M Moxley, Amanda Nickles Fader, et al.
Stem Cells (Dayton, Ohio)|April 23, 2013
Multipotent stromal cells alleviate inflammation, neuropathology, and symptoms associated with globoid cell leukodystrophy in the twitcher mouseBrittni A Scruggs, Xiujuan Zhang, Annie C Bowles, et al.
Gynecologic Oncology|January 17, 2013
A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: a Gynecologic Oncology Group studyR J Schilder, M W Sill, H A Lankes, et al.
Pageof 73